| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/21/2002 | CN1364598A Nano Yiqiyangyuan medicine and its preparing method |
| 08/21/2002 | CN1364597A Nano traumotologic Bali medicine and its preparing method |
| 08/21/2002 | CN1364579A Nano Children Zhibao medicine and its preparing method |
| 08/21/2002 | CN1364577A Nano Yinianjin medicine and its preparing method |
| 08/21/2002 | CN1364576A Nano liver tonifying medicine and its preparing method |
| 08/21/2002 | CN1364572A Nano polystictuc medicine and its preparing method |
| 08/21/2002 | CN1364566A Nano pile fast curing medicine and its preparing method |
| 08/21/2002 | CN1364564A Nano Zisheng medicine and its preparing method |
| 08/21/2002 | CN1364563A Nano Placenta Hominis medicine and its preparing method |
| 08/21/2002 | CN1364560A Nano astragalus root-acanthopanax medicine and its preparing method |
| 08/21/2002 | CN1364557A Nano Jingang medicine and its preparing method |
| 08/21/2002 | CN1364556A Nano Liangge scan medicine and its preparing method |
| 08/21/2002 | CN1364553A Nano aucklandia root and areca seed medicine and its preparing method |
| 08/21/2002 | CN1364552A Nano aucklandia root medicine for keeping adverse energy downwards and its preparing method |
| 08/21/2002 | CN1364549A Nano Sifang gastric medicine and its preparing method |
| 08/21/2002 | CN1364546A Nano middle Jiao regulating aucklandia-amomum fruit medicine and its preparing method |
| 08/21/2002 | CN1364541A Nano Yiqing medicine and its preparing method |
| 08/21/2002 | CN1364539A Nano Yushusan medicine and its preparing method |
| 08/21/2002 | CN1364537A Nano China Ganling medicine and its preparing method |
| 08/21/2002 | CN1364535A Nano eight ingredient Kunshun medicine and its preparing method |
| 08/21/2002 | CN1364531A Nano kidney tonifying and body strengthening medicine and its preparing method |
| 08/21/2002 | CN1364530A Nano kidney tnfiying and brain invigorating medicine and its preparing method |
| 08/21/2002 | CN1364527A Nano five ingredient xianglian medicine and its preparing method |
| 08/21/2002 | CN1364525A Nano body strengthening and brain invigorating medicine and its preparing method |
| 08/21/2002 | CN1364523A Nano secretely produced liver smoothing medicine and its preparing method |
| 08/21/2002 | CN1364519A Nano ginseng fleece-flower root medicine and its preparing method |
| 08/21/2002 | CN1364517A Nano stringy stonecrop medicine and its preparing method |
| 08/21/2002 | CN1364507A Nano seven ingredient axially choerospondias fruit medicine and its preparing method |
| 08/21/2002 | CN1364505A Nano seven ingredient iron filing medicine and its prepairng method |
| 08/21/2002 | CN1364504A nano seven ingredient medicine and its preparing method |
| 08/21/2002 | CN1364496A Nano stagnation resolving hawthorn fruit preparation and its preparing method |
| 08/21/2002 | CN1364489A Nano ten powerful tonics medicine and its preparing method |
| 08/21/2002 | CN1364488A Nano thirteen ingredient Bonga aconite medicine powder and its preparing method |
| 08/21/2002 | CN1364485A Nano ten ingredient pain alleviating medicine and its preparing method |
| 08/21/2002 | CN1364479A Nano gastrodia tuber and fleece-flower root medicine and its preparing method |
| 08/21/2002 | CN1364478A Nano wanyingding medicine and its prepairng method |
| 08/21/2002 | CN1364474A Nano five ingredient turbid substance-clearing medicine and its preparing method |
| 08/21/2002 | CN1364471A Nano seven ingredient ketengzi medicine and its preparing method |
| 08/21/2002 | CN1364462A Tinidazole colon positioning enteric soluble tablet |
| 08/21/2002 | CN1089243C Use of effctive component gentiin in preparing promoting digestion function of stomach and intestine |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6436975 Pharmaceutical compositions for ulcer |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436953 Antisecretory agents, gastrointestinal inflammatory diseases; (7r,8r,9r)-2,3-dimethyl-8-hydroxy-7-methoxy-9-phenyl-7,8,9,10-tetrahydro -imidazo(1,2-h)-(1,7)naphthyridine |
| 08/20/2002 | US6436943 Use of dihydropyrimidines as medicaments, and novel substances |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436922 Treating irritable bowel syndrome |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436447 Evacuant |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2020171C Gastroprotective pharmaceutical preparations containing n-benzyl-n-((1s,5s)-6,6-dimethylbicyclo[3,1,1]-hept-2-ylethoxy-ethyl)-morpholinium salts |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062996A1 Novel physiologically active peptide and use thereof |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062944A2 Novel physiologically active peptide and use thereof |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062794A2 Compounds |
| 08/15/2002 | WO2002062793A1 Thiazole compounds as tgf-beta inhibitors |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062786A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062767A1 Novel quinazoline derivatives |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062753A1 Thiazolamines and their use as tgf-beta inhibitors |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062369A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | WO2002062365A1 Process for producing lamiacea plant extract containing phenols and use thereof |
| 08/15/2002 | WO2002062350A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | WO2002062345A1 Use of galantamine for accelerating transport of intraluminal content |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |